IOTOD Spring webinar, ‘Improving outcomes for opioid-dependent women’

This week the PCM Scientific team hosted the IOTOD spring webinar: ‘Improving outcomes for opioid-dependent women: addressing problems, perceptions and practices within treatment services and beyond’. 

This spring educational session was led by Australian-based Dr Shalini Arunogiri and joined by Dr Bern Hard who is UK based, where they discussed problems faced by opioid-dependent women and their specific needs from treatment services. Furthermore, to share best practice approaches for transferring female patients on daily dose methadone or buprenorphine to long-acting buprenorphine (LAB) and the associated benefits of these treatment formulations in this patient population. Both speakers shared their own examples of their own personal patient stories and the impact this treatment has had on their patients. The webinar was a great success with 84 healthcare professionals across Europe in attendance.

Accessing our community of healthcare professionals via our media brands as well as the well-established IOTOD community, the spring webinar welcomed addiction specialists, psychiatrists, GPs, community pharmacists, primary care nurses and other healthcare professional managing patients with opioid dependence and associated comorbidities. The event concluded with a lively Q&A session.

The IOTOD spring webinar was supported by arms-length funding from Camurus and the archived version will soon be available on the IOTOD website.

Enduring resources and expert-led digital workshops from the HCM Academy

At the end of 2021, PCM Scientific launched a peer-to-peer and online educational programme, the HCM Academy. The website now hosts a series of enduring resources and expert-led digital workshops. 

HCM Academy is a free-to-access CME initiative for family physicians and community cardiologists focusing on the diagnosis and management of Hypertrophic Cardiomyopathy (HCM).

This programme is aimed towards our community of physicians, community cardiologists and healthcare professionals within the USA. With enduring resources created with HCM experts, users can learn best practice in the treatment of patients with HCM, including management of heart failure symptoms and strategies to improve quality of life. 

Resources currently available on the HCM Academy website:

  • 6 online learning modules (1 hour CME per module)
  • 6 online case-study discussions (1 hour CME per case study)
  • Video clips of patient journeys
  • Digital workshops led by 24 regional educators (1 hour CME per workshop)

The digital workshops, targeting three regions of the US, have begun and will run until May 2022. 134 people have participated in the 7 workshops ran so far with another 27 workshops currently booked in until May 2022.

Registration is open for the IOTOD 2022 conference

Registration is now open for the ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD) 2022 conference which returns virtually on 11th – 12th May for its 20th year.

Following the success of our first virtual conference last year, the IOTOD 2022 conference will again provide a range of educational and interactive sessions from the comfort of your own home.

Through expert-led panel discussions and talks from leading figures in the field of opioid dependence, the conference will leave our audience feeling equipped, well informed and ready to improve quality of care in their clinical practice.

Accessing our community of healthcare professionals via our media brands Pulse, Nursing in Practice, The Pharmacist, Hospital Pharmacy Europe and Hospital Healthcare Europe, as well as the well-established IOTOD community, the IOTOD 2022 conference welcomes addiction specialists, psychiatrists, GPs, community pharmacists, primary care nurses and other healthcare professional managing patients with opioid dependence and associated comorbidities. 

 

IOTOD Spring webinar

Following on from the success of our autumn webinar and annual conference, we are pleased to announce that the IOTOD Spring webinar ‘Improving outcomes for opioid-dependent women: addressing problems, perceptions and practices within treatment services and beyond’ will be taking place on Wednesday 23rd February 19:00 GMT on Zoom.

This spring educational session will be led by Australian-based Dr Shalini Arunogiri and joined by Dr Bern Hard who is based in the U.K. This webinar will be looking at the problems faced by opioid-dependent women and their specific needs from treatment services. Furthermore, to share best practice approaches for transferring female patients on daily dose methadone or buprenorphine to long-acting buprenorphine (LAB) and the associated benefits of these treatment formulations in this patient population. The event will conclude with a lively Q&A session.

Accessing our community of healthcare professionals via our media brands Pulse, Nursing in Practice, The Pharmacist, Hospital Pharmacy Europe and Hospital Healthcare Europe, as well as the well-established IOTOD community, the IOTOD Spring webinar welcomes addiction specialists, psychiatrists, GPs, community pharmacists, primary care nurses and other healthcare professional managing patients with opioid dependence and associated comorbidities. 

The IOTOD webinar ‘Improving outcomes for opioid-dependent women: addressing problems, perceptions and practices within treatment services and beyond’ is supported by grant funding from Camurus. The educational programme is run at arm’s length from the financial supporters and all content is created by the faculty. No funder has had input into the content of the materials or presentations used in the educational programme. PCM Scientific is the medical education company acting as scientific secretariat and webinar organiser.

Introducing the HCM Academy

Introducing the HCM Academy, our brand-new medical education programme from PCM Scientific. 

PCM Scientific have recently launched a brand-new medical programme, the HCM Academy. A free-to-access CME initiative for family physicians and community cardiologists focusing on the diagnosis and management of Hypertrophic Cardiomyopathy (HCM).

This new programme is aimed towards our community of physicians, community cardiologists and healthcare professionals within the United States of America. Alongside leading HCM experts, users can learn best practice in the treatment of patients with HCM, including management of heart failure symptoms and strategies to improve quality of life.

It will run until May 2022 and will offer two main learning streams: live digital CME workshops and online CME modules. Included on the HCM Academy platform will be 60-minute live workshops delivered by a regional educator and HCM expert, online educational modules, case studies, and patient videos.

 

A.S.K webinar series

Three webinars from A.S.K, PCM Scientific’s medical education programme, took place across November 2021. With each expert-led webinar providing in-depth discussions around the adaptation and usage of biosimilars medication in the treatment of patients with cancer.

Following the success of the three live webinars in November, a 10-chapter educational handbook was developed and is available to download on the website. This handbook closely investigates the use of in monoclonal antibody biosimilars to promote best clinical practice of treating patients with solid tumours.

ASK consists of dynamic, interactive, and multi-format educational activities, and in 2022 the website will feature the 10 learning chapters, a library of 30 abstracts, local guideline summary documents, and an archive of the three webinars. All educational resources will be translated into French, German, Italian, Spanish and Japanese. This programme specifically targets clinicians in Western Europe, Canada and Japan. Other members of the multidisciplinary team are also encouraged to make use of these resources.

The programme’s resources will be marketed through paid social media campaigns, newsletters and online ads through the ASK social media platforms and with the help of faculty and worldwide societies. Marketing avenues also include our media brands Hospital Pharmacy Europe and Hospital Healthcare Europe.

First A.S.K webinar

The first of three webinars from A.S.K, our new medical education programme, took place this month and discussed adapting to the use of biosimilar medications in the treatment of patients and the factors to consider when adding a biosimilar medication to the formulary.

The first A.S.K webinar, ‘Adapting to a changing landscape: switching to oncology biosimilars’, featured discussion from our expert faculty, Emma Foreman, Phillippe Arnaud and Glenn Myers.

A.S.K.– Attitude, Skills and Knowledge in Oncology Biosimilars, is a new medical education programme aimed at the hospital-based pharmacist community to provide education that will increase their knowledge and confidence in using biosimilar medications when treating oncology patients.

A further two case study webinars will be taking place on the 24th and 30th November 2021, covering the topics of patient engagement and pharmacovigilance when implementing biosimilar medications. Alongside the webinars, an educational handbook has been developed and is available to download on the website.

In 2022 the website will also feature 10 learning chapters, a library of 30 abstracts and local guideline summary documents, with all resources translated into French, German, Italian, Spanish and Japanese. This programme specifically targets clinicians in Western Europe, Canada and Japan. Other members of the multidisciplinary team are also encouraged to make use of these resources.

The programme’s resources will be marketed to our hospital-based pharmacist community, including via our media brands Hospital Pharmacy Europe and Hospital Healthcare Europe.

New medical education programme, A.S.K.

PCM Scientific have recently launched a new medical education programme educating healthcare professionals on biosimilars in the oncology space: A.S.K. – Attitude, Skills and Knowledge in Oncology Biosimilars.

This new medical education programme is aimed towards our community of hospital-based pharmacists to provide education that will increase their knowledge and therefore confidence on using biosimilars when treating patients. This programme specifically targets clinicians in Western Europe, Canada and Japan and other members of the MDT are also encouraged to view these resources.

Currently there is an educational handbook live and three webinars scheduled in for November.

By 2022 the website will also feature 10 learning chapters, a library of 30 abstracts, and country guideline summary documents, with all resources translated into French, German, Italian, Spanish and Japanese.

The programmes resources will be marketed through paid social media campaigns, newsletters and online ads through the ASK social media platforms and with the help of faculty and worldwide societies. Marketing avenues also include our media brands, Hospital Pharmacy Europe and Hospital Healthcare Europe.

 

Heart Education Europe Journal Clubs

This month PCM Scientific have re-launched Heart Education Europe with a series of educational journal clubs available on the site.  

Heart Education Europe is an educational initiative that explores the emerging data surrounding clinical interventions in heart failure management to help cardiology professionals across Europe stay abreast of evolving practices.

The journal clubs featured on the website are engaging, interactive discussions of a selection of papers and latest clinical outcome studies determined by our dedicated Heart Education Europe faculty to ensure cardiology professionals keep up to date with heart failure management.

These educational sessions were led by Prof. Andrew Coats who was joined by Prof. Javed Butler, Prof. Faiez Zannad and Prof. Stefan Anker where they discussed the data and advancements in heart failure management from the EMPEROR-Reduced trial.

Moreover, the Heart Education Europe activities are also available as eLearning modules for accruing CPD points – allowing our audience of European clinicians to stay-up-to date with the latest in heart failure management.

This independent educational activity is supported by funding from The Boehringer Ingelheim and Lilly Alliance. PCM Scientific is the medical education company acting as scientific secretariat and organiser for this programme. The activity is run independently of the financial supporter and all content is created by the faculty. No funder has had input into the content of the activity.

IOTOD: Autumn Webinar

Developed by PCM Scientific, the IOTOD autumn webinar will be looking at perspectives from both opioid-dependent treatment providers and patients surrounding the use of long-acting buprenorphine (LAB) in different treatment scenarios and treatment journey stages.

Following on from the success of our summer webinar and annual conference, we are pleased to announce that the IOTOD autumn webinar ‘Transfer to long-acting buprenorphine from full opioid agonists in different dependent demographics: do’s, don’ts, and why does it matter?’ will be taking place on Monday 25th October 13:00 BST on Zoom.

This autumn educational session will be led by US-based Dr Michael Frost and joined by Professor Michael Soyka who is based in Germany. This webinar will be looking at perspectives from both opioid-dependent treatment providers and patients surrounding the use of long-acting buprenorphine (LAB) in different treatment scenarios and treatment journey stages.

They will also discuss best practice approaches for transferring patients from daily dose methadone or buprenorphine to LAB, potential transfer outcomes and next steps. The event will conclude with a lively Q&A session.

The IOTOD webinar was supported by arms-length funding from Camurus and the archived version will soon be available on the IOTOD website.

2021 PCRA Webinar series now available for on-demand viewing

This year the Primary Care Respiratory Academy (PCRA) was held digitally as a series of eight interactive and educational webinars: six clinical and two quality improvement webinars, and is now available for on-demand viewing.

Hundreds tuned in live to the webinars which ran throughout the summer. If you missed any or want to watch them again, all eight webinars are available for on-demand viewing on the PCRA website.

The Clinical webinar series featured Steve Holmes and Ren Lawlor who were joined throughout the series by Carol Stonham, Dominika Froehlich-Jeziorek and Fiona Mosgrove. Topics covered diagnosis, management and real-world challenges of asthma and COPD.

The Quality Improvement webinars featured interactive discussions with Daryl Freeman and Sanjeev Rana with special guests Charlie Sharp and Vincent Mak. Topics of discussion included ongoing symptomatic COVID-19 vs. post-COVID-19 syndrome, the value of a holistic care approach, real-world practice implications and lessons learnt from the pandemic, and the management of asthma & COPD.

Many viewers submitted questions to our speakers during the live clinical webinars but there was not enough time to answer them all. The speakers have responded to some of the most frequently asked questions. Check out the Q&A documents available with the clinical webinar series.

We are already busy planning for the 2022 programme! If you would like to have a say in what next year’s PCRA programme will cover, fill in this quick survey.

IOTOD Summer Webinar

Following on from the success of our spring webinar and annual conference, PCM Scientific are pleased to announce that the IOTOD (Improving Outcomes in the Treatment of Opioid Dependence) summer webinar will be taking place on Monday 21st June 16:00 BST.

The educational session will be looking at long-acting buprenorphine in the treatment of opioid dependence and striking the balance between greater freedom and strong engagement.

This summer webinar will be led by Dr Julia Lewis alongside Dr Steve Brinksman, where they will discuss the significance of taking a holistic approach when providing treatment for opioid dependence.

The event will also explore the sharing of clinical best-practice involving OST – particularly when using long-acting buprenorphine (LAB) formulations – to support adherence, good quality of life and mental health, and overall treatment success. Both speakers will share their own personal patient stories and the impact this treatment has had on their patients, adding in a case-based element to their talks.

Accessing our community of healthcare professionals via our media brands, the webinar welcomes addiction specialists, psychiatrist and psychologists, GPs, community pharmacists, hepatologists, primary care nurses, hospital pharmacists and other healthcare professional managing patients with opioid dependence and associated comorbidities, from the UK and across Europe. The event will conclude with a healthy and lively Q&A session.

An archived version of the summer webinar will later be hosted on the IOTOD website.

Launch of HCP Connect

Cogora are delighted to announce the launch of HCP ConnectTM, a new virtual event platform which has been designed specifically for the healthcare market.

Developed after feedback from industry and delegates and a huge number of lessons learnt from virtual events in 2020, Cogora are currently running our own events, including Pulse LIVE, Nursing in Practice and IOTOD 2021, on HCP ConnectTM.

Over 7,500 HCPs, including UK and international, are currently registered to attend these events which, due to the flexibility of this platform, run over three months and cover multiple clinical and professional areas.

The platform is now available for use by clients. Whether you are already planning a virtual event, have standalone webinars to run where you would like wraparound promotional activity or are looking to H2 and the possibilities of hybrid events, please do get in touch with any questions edwardburkle@cogora.com.

Key features

  • Fully customisable
  • Designed in order to accommodate ABPI and compliance considerations
  • Ease of use – specially designed to be easy for delegates to navigate and familiar for speakers
  • Fully secure and tiered access – authenticate registrations and offer or restrict delegates access to specific content depending on their role
  • Mixed media, branded virtual exhibition stands: including video, url, pdf and more
  • Full data reporting on visits, demographic, user journey, live and on-demand views and more including real-time sponsor dashboards
  • Fully managed – we will take the hard work out of the process whilst allowing review access for approval and sign off
  • Guaranteed SOPs so you can be sure material will be removed or amended should it be required

The annual IOTOD conference returned

On the 26th and 27th April, the annual Improving Outcomes in the Treatment of Opioid Dependence (IOTOD) returned for its 19th year and for the second time as a virtual conference.

Across the two days, 316 people turned in from across the globe to watch leading experts provide their insight on hot topics within the field, including:

  • Evolving patient populations and the role of the digital dealer
  • Treating opioid-dependent patients in the COVID-era
  • Identifying and managing opioid analgesia dependence – including the perspectives of a former patient
  • Available long-acting formulations and the perspectives of these treatments from patients and non-medical prescribers
  • Testing for and treating HBV and HCV

The conference then ended with an interactive and passionate panel discussion take place where 5 complex cases were debated between 5 key leaders in the field of opioid dependence.

All of the main plenary content is available to view on-demand on the IOTOD 2021 conference platform until 27th May.

Can we offer our opioid-dependent patients greater freedom?

This week the PCM Scientific team hosted the IOTOD webinar ‘Can we offer our opioid-dependent patients greater freedom? Looking at outcomes with long-acting buprenorphine formulations’.

This spring educational session was led by London based Dr Michael Kelleher, who was joined by Dr Bernadette Hard and (nurse specialist) Mrs Lisa Kieh both from Wales, where they discussed the significance of patient freedom as part of an effective management strategy for opioid dependence.

The event also explored the sharing of best-practice treatment approaches using long-acting buprenorphine formulations including patient-reported outcomes and perspectives from a key national pilot in Wales. Both speakers shared their own examples of their own personal patient stories and the impact this treatment has had on their patients, adding in a human element to their talks.

The webinar was a great success with over 270 in attendance and reaching places including the UK, many countries across Europe and even as far as New Zealand. The event concluded with healthy and lively Q&A session and it was evident the audience members wanted this to continue due to the number of submitted questions!

The IOTOD webinar was supported by grant funding from Camurus and the archived version will soon be available on the IOTOD website.

IOTOD 2021 conference

Registration is now open for the annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD) conference which returns virtually on 26th – 27th April for its 19th year.

Following the success of our first virtual conference last year, the IOTOD 2021 conference will again provide a range of educational and interactive sessions from the comfort of your own home.

Through expert-led panel discussions and talks from leading figures in the field of opioid dependence, the conference will leave our audience feeling equipped, well informed and ready to improve quality of care in their clinical practice.

Open to all healthcare professionals interested in this field, registration is now open.

Can we offer opioid-dependent patients greater freedom?

Next month, PCM Scientific will be hosting a spring educational session exploring how opioid-dependent patients are being offered greater freedom through treatment.

The free event is taking place on 23rd February and will be led by Dr Michael Kelleher, who will be joined by Dr Bernadette Hard and nurse specialist Mrs Lisa Kieh. During the live 60-minue event, the expert panel will be discussing the significance of patient freedom along with the sharing of best-practice treatment approaches using long-acting buprenorphine as part of an effective management strategy for opioid dependence.

The educational session will also explore patient-reported outcomes and perspectives from a key national pilot in Wales as well the challenges faced during the COVID-19 pandemic. There will also be the opportunity to hear directly from a patient and his perspectives on what freedom means to him and how treatment has impacted his daily life. Audience members will be encouraged to submit questions for the live Q&A during the event, providing a platform for what hopes to be a lively discussion!

The IOTOD webinar is supported by grant funding from Camurus.

Merry Christmas from Cogora

With year-end quickly approaching, the Cogora team would like to wish you a Merry Christmas and Happy New Year!

2020 brought new challenges and new ways of working. Covid-19 had a major effect on healthcare professionals’ media and educational consumption, with the industry then forced to look at ways to embrace these changes for the future.

Across our media brands we saw a greater demand for access to information and guidance as it emerges and the need for a reliable and trusted source to deliver it. Regular Covid-19 specific news articles have consistently proven to be the most popular type of content, so our streams of updates attracted swathes of online traffic. All our brands set up dedicated Covid-19 sections on their websites to help readers easily navigate the myriad of information related to the crisis.

With only three face-to-face events delivered before the pandemic hit, our media brand Events team pivoted to virtual events and, through Autumn, over 6,500 healthcare professionals logged in to our Pulse, Nursing in Practice and Management in Practice Events to experience live and on-demand webinars and visit virtual exhibition stands.

Cogora: The Agency hosted numerous advisory boards and roundtable meetings, both face to face and virtual, across many different therapy areas with delegates ranging for c-suite personnel to clinical multi-disciplinary teams in primary and secondary care. Included was what was meant to be a two day live conference in the field of rare diseases, which instead became a highly successful virtual meeting.

Delegates from across the world were able to learn and engage with leaders in the field. Meeting feedback was so well received that a second meeting is already being planned for 2021. The annual Primary Care Respiratory Academy Roadshow also had to be converted to series of regional interactive webinars with over 600 attendees.

Other highlights included the development and launch of an app for young people with cystinosis as they transition from paediatric to adult care, the launch of a digital hub hosting varied resources including animation, clinical paper summaries and talking head videos as well as CPD accredited learning modules.  

Within our CME division, PCM Scientific, we hosted our 18th annual IOTOD conference in a virtual environment for the first time, with over 350 delegates from over 40 countries in attendance across the two day live-streamed event. Two new educational platforms were launched in cardiology education for a European and USA audience, we hosted educational webinars discussing the diagnosis and management of allergies during a beyond Covid-19 in five local languages, and launched a series of educational e-Learning modules within the areas of coeliac disease, thyroid cancer and acute myeloid leukaemia across our educational platforms.

Allergy Diagnosis and Management and Diagnosis beyond Covid-19

Last month PCM Scientific held five country-specific webinars on ”Allergy diagnosis and management during and beyond Covid-19”, which will be archived on the Alliance Allergy platform.

The aim was to explain the main learnings from EAACI guidelines alongside country-specific guidance and to support primary care doctors and allergy specialists in their clinical practice. The main objectives were to learn practical tips to optimise allergy diagnosis and management beyond the Covid-19 pandemic, and to be able to conduct a diagnosis to differentiate Covid-19 from allergic rhinitis.

The Alliance Allergy platform currently hosts a series of modules, case studies and resources to improve clinical knowledge surrounding the diagnosis of allergic diseases, the administration of appropriate care and the recognition of when specialised care is required.

NOAC Education satellite symposium

This month, NOAC Education hosted an educational satellite symposium at the European Emergency Medicine (EUSEM) Congress in Prague, Czech Republic.

The interactive symposium entitled ‘NOAC Reversal in Emergency Medicine’ was chaired by Professor Ander Cohen. With 177 delegates engaged in the session, Dr David Julian Seiffge, Dr Jecko Thachil and Professor Michael Christ educated the audience on how and when to utilise NOACs, and the latest management strategies available for NOAC reversal in the event of a major life-threatening bleed or emergency surgery, with thought-provoking case-studies included.

With audience voting via an app and the chance to gain expert insights, this session was thoroughly enjoyed by all, with questions being submitted right until the very end. 

Watch out for the symposium footage coming soon on the NOAC Education website.

Free educational activities to aid stroke prevention

The NOAC Education platform contains a range of free, digital activities where top experts in stroke prevention provide digestible information and guidance on managing practical issues that arise in patients receiving anticoagulation.

NOAC Education provides time-pressed clinicians a convenient, tailored learning experience: live 30-minute webinars (Journal Clubs) with a unique opportunity to pose questions to authors of novel and practice changing studies, archived Journal Clubs webinars to watch anytime, recordings of NOAC Education symposia at international conferences events and expert-led case study resolution videos.

Moreover, the NOAC Education activities are available as instant open-access eLearning for those short on time or as a registered accredited eLearning for accruing CPD points – allowing clinicians to stay-up-to date with the latest in anticoagulation in the format and duration that is most valuable to them.

Upcoming activities:

Brand new: NOAC Myth-buster

Animation video dispelling common misconceptions. The animation will cover a visual illustration of non-specific reversal of anticoagulation by prothrombin complexes (PCCs) and understanding of newer specific reversal by fXa inhibitors.

Brand new: NOAC poster sessions

A unique opportunity to review scientific posters and pose questions on study methodology, results and learning lessons directly to the expert study author and chair Professor John Camm for an informative analysis of the data.

Poster 1: Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in non-valvular atrial fibrillation – a cohort study in the 3 Scandinavian countries – Professor Søren Paaske Johnsen

Poster 2: Modifications of renal function in atrial fibrillation patients treated with different oral anticoagulants: a multicentre cohort stud – Assistant Professor Daniele Pastori

Ongoing Journal Club series looking at the latest studies and the implications for improved clinical practice:

  • Having covered the ANNEXA-4 interim analysis in a past NOAC Journal Club, the latest webinar will see study author Dr Stuart Connolly discuss the full study results where the performance of first-in-kind fXa inhibitor reversal agent andexanet alfa is evaluated for safety and effectiveness criteria in patients with acute major bleeding.
  • Join Dr John Eikelboom who will discuss a pivotal study on 2,200 patients. Of these patients with atherosclerosis requiring anticoagulation, an association was seen between anticoagulant-induced gastrointestinal or genitourinary bleeding and higher rates of cancer. 

Access the NOAC Education platform now to access this indispensable educational resource.

You can also sign-up to the NOAC eNewsletter to be informed of newly-released NOAC Education activities. 

 

Oncology Nursing in Practice: Smoking Cessation

PCM Scientific has launched a new accredited module ‘Smoking Cessation’, on the Oncology Nursing in Practice platform, to educate on the importance and process of quitting smoking for patients with cancer, and ways to support patients through their journey.

Successful smoking cessation is life-changing, giving patients the opportunity to live longer and improved lives; this new module aims to provide nurses with knowledge to support their daily practice.  
The UK government has recently pledged to end smoking in England by 2030 and, while this new module focuses on people diagnosed with lung cancer, it contains education that can be applied to any patient who smokes. 
 

Hepatitis C virus in people who inject drugs (PWID): Regional Webinar

The IOTOD educational platform now features an expert-led South East Asia webinar on treatment of HCV in people who inject drugs (PWID).

With European and regional perspectives on best management of this patient population, the latest data concerning diagnostic and management approaches are shared alongside practical advice to support healthcare professionals across the globe in working towards the WHO HCV elimination goal by 2030.  

New Oncology Nursing in Practice modules

Specifically designed for oncology nurses to improve their patient’s treatment journey, the Oncology Nursing in Practice (ONiP) platform has launched a further two eLearning modules across Europe this month: Palliative Care, and Head and Neck Cancer – Post-surgery.

Accredited by the Federation of the Royal Colleges of Nursing (RCN), the ONiP modules identify key areas where oncology nurses have requested further education to help meet their day-to-day challenges. We aim to fill this knowledge gap and help provide nurses with the tools they need to confidently care for their patients. 

To raise awareness surrounding their addition to the programme, the PCM Scientific team will be exhibiting ONiP at the upcoming British Association of Head and Neck Oncology Nurses annual conference in Glasgow. Further insights will be also be gathered surrounding Oncology Nurse needs for future educational developments.